Skip to main content
Fig. 6 | Applied Biological Chemistry

Fig. 6

From: Therapeutic effects of sesamolin on leukemia induced by WEHI-3B in model mice

Fig. 6

Effects of sesamolin on liver and spleen weight. Effects of sesamolin on liver and spleen weight were assessed under the same experimental conditions as those illustrated in Fig. 5. A Photographs of spleen and liver. B Spleen and liver weights. Data are representative of experiments repeated at least three times with triplicate samples and are shown as mean ± SD. *P < 0.05 vs. group 3 (one-way ANOVA with Dunnett’s post-hoc tests). Group 1, normal BALB/c mice; group 2, normal BALB/c mice administered with 10 mg/kg sesamolin in CMC from day 5; group 3, WEHI-3B-injected BALB/c mice; group 4: WEHI-3B-injected BALB/c mice administered with 10 mg/kg sesamolin in CMC from day 0; group 5, WEHI-3B-injected BALB/c mice administered with 10 mg/kg sesamolin in CMC from day 5

Back to article page